{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:54:52Z","timestamp":1782258892740,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["91218013"],"award-info":[{"award-number":["91218013"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["01492947"],"award-info":[{"award-number":["01492947"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003143","name":"Fonds Psychische Gezondheid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003143","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Metabolic Power Foundation"},{"name":"Friends of Beatrix Childrens Hospital"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.parkreldis.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T09:32:22Z","timestamp":1582018342000},"page":"44-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A detailed description of the phenotypic spectrum of North Sea Progressive Myoclonus Epilepsy in a large cohort of seventeen patients"],"prefix":"10.1016","volume":"72","author":[{"given":"Sjoukje S.","family":"Polet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette H.","family":"Koens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martje E.","family":"van Egmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gea","family":"Drost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Brusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8l AAP.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Sival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oebele F.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus PH.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina AJ.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2020.02.005_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ajhg.2011.04.011","article-title":"A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia","volume":"88","author":"Corbett","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awt021","article-title":"\u2018North Sea\u2019 progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation","volume":"136","author":"Boiss\u00e9 Lomax","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/39923","article-title":"A SNARE involved in protein transport through the Golgi apparatus","volume":"389","author":"Lowe","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mds.25704","article-title":"Clinical characterization of progressive myoclonus ataxia caused by GOSR2 mutation","volume":"29","author":"van Egmond","year":"2014","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.02.005_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mdc3.12372","article-title":"Deep brain stimulation in three related cases of North Sea progressive myoclonic epilepsy from South Africa","volume":"4","author":"Anderson","year":"2016","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13023-017-0595-3","article-title":"The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study","volume":"12","author":"van Egmond","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.410280129","article-title":"Classification of progressive myoclonus epilepsies and related disorders","volume":"28","author":"Marseille Consensus Group","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1990.00530100091019","article-title":"Progressive myoclonic ataxia (the Ramsay Hunt syndrome)","volume":"47","author":"Marsden","year":"1990","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/mds.27412","article-title":"Progressive myoclonus ataxia: time for a new definition?","volume":"33","author":"van der Veen","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib10","first-page":"271","article-title":"Expanding the phenotype and genetic defects associated with the GOSR2 gene","volume":"2","author":"Praschberger","year":"2015","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.02.005_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-018-0163-0","article-title":"TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of \u03b1-dystroglycan and muscular dystrophy","volume":"8","author":"Larson","year":"2018","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.nmd.2013.06.404","article-title":"GOSR2: a novel form of congenital muscular dystrophy","volume":"23","author":"Tsai","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pds.3498","article-title":"Use of antiepileptic drugs and risk of hypothyroidism","volume":"22","author":"Lai","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajhg.2008.10.003","article-title":"A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome","volume":"83","author":"Bassuk AG","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1528-1167.2006.00553.x","article-title":"Unverricht-lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients","volume":"47","author":"Magaudda","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib17","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1111\/j.1528-1167.2011.03307.x","article-title":"Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations","volume":"52","author":"Rubboli","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1474-4422(14)70011-0","article-title":"ATP1A3 Working Group. Distinct neurological disorders with ATP1A3 mutations","volume":"13","author":"Heinzen","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpn.2017.12.009","article-title":"ATP1A3-related disorders: an update","volume":"22","author":"Carecchio","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib20","first-page":"1","article-title":"GNAO1 encephalopathy: broadening the phenotype and evaluating treatment and outcome","volume":"21","author":"Danti","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10545-018-0205-0","article-title":"Postsynaptic movement disorders: clinical phenotypes, genotypes and disease mechanisms","volume":"41","author":"Abela","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1528-1167.2009.02115.x","article-title":"Clinical spectrum of SCN1A mutations","volume":"50","author":"Gambardella","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.celrep.2017.09.004","article-title":"Mutations in membrin\/GOSR2 reveal stringent secretory pathway demands of dendritic growth and synaptic integrity","volume":"21","author":"Praschberger","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.parkreldis.2020.02.005_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2019.03.057","article-title":"Mechanisms of neurological dysfunction in GOSR2 progressive myoclonus epilepsy, a golg SNAREopathy","volume":"420","author":"Jepson","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2020.02.005_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.10.035","volume":"423","author":"Lambrechts","year":"2019","journal-title":"Neuroscience"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020300341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020300341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:18:23Z","timestamp":1761178703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020300341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":25,"alternative-id":["S1353802020300341"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.005","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A detailed description of the phenotypic spectrum of North Sea Progressive Myoclonus Epilepsy in a large cohort of seventeen patients","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}